Lorlatinib and the Enigma of Autoantibody-Negative Diabetes
Patients on lorlatinib may develop diabetes with unusual characteristics, including the absence of typical autoantibodies. This presents a diagnostic challenge, requiring clinicians to consider drug-induced etiologies even when initial immunological markers are negative.
Does Intrinsic Capacity Truly Predict Geriatric Outcomes?
Older inpatients often present with a constellation of geriatric syndromes, but predicting who will decline is challenging. This study suggests that assessing multiple domains of intrinsic capacity might offer some predictive value, though the effect sizes raise questions.
SPI1 Mutations Expand the Agammaglobulinemia Genetic Map
A novel de novo SPI1 mutation has been identified in a Chinese patient with agammaglobulinemia, adding another piece to the complex genetic puzzle of this primary immunodeficiency. This finding suggests that SPI1 should be considered in the diagnostic workup of patients with unexplained B-cell deficiency, particularly in cases where other known genetic causes have been excluded.
Lipophosphonoxins The Next Generation Antibiotics?
Antimicrobial resistance poses an increasing threat, demanding innovative therapeutic strategies. Lipophosphonoxins (LpxNs) are emerging as promising broad-spectrum antibacterial agents that target LpxC, an essential enzyme in bacterial lipid A synthesis, circumventing common resistance mechanisms.
Pulmonary Embolism from a Surprising Source
Pulmonary embolism, while often linked to deep vein thrombosis, can arise from unexpected sources. This case highlights the need for clinicians to consider rare etiologies in unexplained PE.
